Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
Kadayifci
Abdurrahman
A
Merriman
Raphael B
RB
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000975:Antioxidants / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001706:Biopsy; D015992:Body Mass Index; D004038:Diet, Reducing; D005234:Fatty Liver / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006505:Hepatitis / Q000473:pathology; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology; D008103:Liver Cirrhosis / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000178:diet therapy / Q000188:drug therapy; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use*
D000975:Antioxidants; D007004:Hypoglycemic Agents; D014810:Vitamin E; D008687:Metformin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase